Data Dictionary: Pancreatic cancer - DPCA - Revision history

Larysse at 17:42, 4 December 2025

2025-12-04T17:42:35Z

← Older revision		Revision as of 17:42, 4 December 2025
Line 1:		Line 1:
	<span style="display:none">forresearchers</span>		<span style="display:none">forresearchers</span>
			<span style="display:none">thenetherlandscountry</span>
	Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.		Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.

Lucas: Update categories.

2025-12-02T13:26:50Z

Update categories.

← Older revision		Revision as of 13:26, 2 December 2025
Line 1:		Line 1:
	{{forresearchers}}		<span style="display:none">forresearchers</span>
	Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.		Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.

Victor: Victor moved page Data Dictionary: Pancreatic cancer – DPCA to Data Dictionary: Pancreatic cancer - DPCA

2024-09-17T20:29:41Z

Victor moved page Data Dictionary: Pancreatic cancer – DPCA to Data Dictionary: Pancreatic cancer - DPCA

← Older revision	Revision as of 20:29, 17 September 2024
(No difference)

Victor at 00:18, 27 August 2024

2024-08-27T00:18:31Z

← Older revision		Revision as of 00:18, 27 August 2024
Line 104:		Line 104:
	\| Date of the last preoperative imaging		\| Date of the last preoperative imaging
	\|-		\|-
	\| Presence of a ~~tumor~~ in the pancreas or periampullary on CT or MRI		\| Presence of a tumour in the pancreas or periampullary on CT or MRI
	\|-		\|-
	\| Cystic features suggestive of malignancy		\| Cystic features suggestive of malignancy
Line 139:		Line 139:
	\| Operative details including ASA score, type of resection, and operative complications		\| Operative details including ASA score, type of resection, and operative complications
	\|-		\|-
	\| Postoperative pathology including ~~tumor~~ origin, size, and grade		\| Postoperative pathology including tumour origin, size, and grade
	\|}		\|}

Line 241:		Line 241:
	\| Is cytology or histology obtained during the diagnostic process?		\| Is cytology or histology obtained during the diagnostic process?
	\|-		\|-
	\| Most likely origin of the ~~tumor~~		\| Most likely origin of the tumour
	\|-		\|-
	\| Histological diagnosis?		\| Histological diagnosis?
	\|}		\|}

	'''Table 21:''' ~~Tumor~~ Characteristics.		'''Table 21:''' Tumour Characteristics.
	{\| class="wikitable"		{\| class="wikitable"
	! Variables		! Variables
	\|-		\|-
	\| Largest ~~tumor~~ diameter in cm		\| Largest tumour diameter in cm
	\|-		\|-
	\| Smallest margin in cm (radicality)		\| Smallest margin in cm (radicality)
	\|-		\|-
	\| ~~Tumor~~ differentiation grade		\| Tumour differentiation grade
	\|-		\|-
	\| Neuroendocrine ~~tumor~~ differentiation grade		\| Neuroendocrine tumour differentiation grade
	\|-		\|-
	\| pT-stage pancreatic carcinoma according to TNM8		\| pT-stage pancreatic carcinoma according to TNM8
Line 273:		Line 273:
	\| Number of lymph nodes found		\| Number of lymph nodes found
	\|-		\|-
	\| Number of ~~tumor~~-positive lymph nodes found		\| Number of tumour-positive lymph nodes found
	\|-		\|-
	\| Distant metastases?		\| Distant metastases?
Line 282:		Line 282:
	! Variables		! Variables
	\|-		\|-
	\| Pathological response after neoadjuvant therapy with Histological ~~Tumor~~ Regression Grading (HTRG)		\| Pathological response after neoadjuvant therapy with Histological Tumour Regression Grading (HTRG)
	\|}		\|}

Larysse at 09:24, 25 May 2024

2024-05-25T09:24:41Z

Show changes

Larysse at 09:07, 25 May 2024

2024-05-25T09:07:25Z

← Older revision		Revision as of 09:07, 25 May 2024
Line 1:		Line 1:
			{{forresearchers}}
	Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.		Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.

	This is a summary of the variables available in the database. You can download the complete data dictionary. [https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more].		This is a summary of the variables available in the database. You can download the complete data dictionary here: [https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more].

	~~'''~~Patient Demographics and Identification~~:'''~~		{\| class="wikitable"
	* Healthcare Institution ~~(Zorginstelling)~~		! Patient Demographics and Identification
	* Unique Patient Number ~~(Uniek Patiëntnummer)~~		\|-
	* Social Security Number ~~(Burger Service Nummer)~~		! Variables !! Description
	* Surname ~~(Geslachtsnaam)~~		\|-
	* Date of Birth ~~(Geboortedatum)~~		\| Zorginstelling \|\| Healthcare Institution
	* Gender (~~Geslacht~~)		\|-
	* Country (Country of Residence) ~~(Land (Woonadres))~~		\| Uniek Patiëntnummer \|\| Unique Patient Number
	* Postal Code (~~Postcode~~)		\|-
	* Date of Death (if applicable) ~~(Datum overlijden (indien van toepassing))~~		\| Burger Service Nummer \|\| Social Security Number
			\|-
			\| Geslachtsnaam \|\| Surname
			\|-
			\| Geboortedatum \|\| Date of Birth
			\|-
			\| Geslacht \|\| Gender
			\|-
			\| Land (Woonadres) \|\| Country (Country of Residence)
			\|-
			\| Postcode \|\| Postal Code
			\|-
			\| Datum overlijden (indien van toepassing) \|\| Date of Death (if applicable)
			\|}


	~~'''~~Comorbidities~~:'''~~		{\| class="wikitable"
	* Comorbidities, with options to add a new record or update based on changes or previous registrations ~~(Comorbiditeiten)~~		! Comorbidities
			\|-
			! Variables !! Description
			\|-
			\| Comorbiditeiten \|\| Comorbidities, with options to add a new record or update based on changes or previous registrations
			\|}

			{\| class="wikitable"
			! Medical Procedures
			\|-
			! Variables !! Description
			\|-
			\| Verrichtingen \|\| Procedures, where multiple procedures per patient can be registered if applicable
			\|}

	~~'''Medical Procedures:'''~~		{\| class="wikitable"
	* Procedures, ~~where multiple procedures per patient can be registered if applicable (Verrichtingen)~~		! COVID-19 Module
			\|-
			! Variables !! Description
			\|-
			\| Deze generieke COVID-19 module \|\| A generic COVID-19 module added due to the impact of the coronavirus crisis on the quality of care, allowing for the better interpretation of indicators during this period
			\|}

			{\| class="wikitable"
			! Pathology Variables through PALGA
			\|-
			! Variables !! Description
			\|-
			\| In het kader van de PALGA-koppeling worden pathologie variabelen \|\| Pathology variables automatically structured and included in the registration via the PALGA-pathology module, requiring no additional data
			\|}

	~~'''COVID~~-~~19 Module:'''~~		{\| class="wikitable"
	* A generic COVID-~~19 module added due to the impact of the coronavirus crisis on the quality of care, allowing~~ for ~~the better interpretation of indicators during this period (Deze generieke COVID~~-~~19 module)~~		! Patient Identification and Treatment Timeline
			\|-
			\| Treatment start date
			\|-
			\| Reason for registration
			\|-
			\| Hospital patient number
			\|}

			{\| class="wikitable"
	~~'''Pathology Variables through PALGA:'''~~		! Patient Physical and Performance Metrics
	* Pathology variables automatically structured and included in the registration via the PALGA-pathology module, requiring no additional data (In het kader van de PALGA-koppeling worden pathologie variabelen)		\|-
			\| Height in cm
			\|-
	~~'''Patient Identification and Treatment Timeline'''~~		\| Preoperative weight in kg
	* Treatment start date		\|-
	* Reason for registration		\| Weight loss in kg and period in weeks
	* Hospital patient number		\|-
			\| ECOG performance status (Eastern Cooperative Oncology Group)
			\|}
	~~'''~~Patient Physical and Performance Metrics~~'''~~
	* Height in cm
	* Preoperative weight in kg
	* Weight loss in kg and period in weeks
	* ECOG performance status (Eastern Cooperative Oncology Group)

Victor at 21:42, 8 May 2024

2024-05-08T21:42:20Z

← Older revision		Revision as of 21:42, 8 May 2024
Line 1:		Line 1:
	Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.		Go back to [[Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands)]] page.

	This is a summary of the variables available in the database. You can download the complete data dictionary. [[https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more].		This is a summary of the variables available in the database. You can download the complete data dictionary. [https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more].

	'''Patient Demographics and Identification:'''		'''Patient Demographics and Identification:'''

Victor at 21:36, 8 May 2024

2024-05-08T21:36:57Z

← Older revision		Revision as of 21:36, 8 May 2024
Line 118:		Line 118:
	* ICU admission and discharge dates and durations.		* ICU admission and discharge dates and durations.
	* Destination after ICU discharge.		* Destination after ICU discharge.


			'''Sample Information'''
			* Date of tissue arrival at laboratory
			* Pathology laboratory
			* Pathology number (TJJ-CCCCCC)
			* Protocol
			* Sample number


			'''Diagnostic Details'''
			* Is cytology or histology obtained during the diagnostic process?
			* Most likely origin of the tumor
			* Histological diagnosis?


			'''Tumor Characteristics'''
			* Largest tumor diameter in cm
			* Smallest margin in cm (radicality)
			* Tumor differentiation grade
			* Neuroendocrine tumor differentiation grade
			* pT-stage pancreatic carcinoma according to TNM8
			* Papil of Vater carcinoma according to TNM8
			* Distal cholangiocarcinoma according to TNM8
			* Duodenum carcinoma according to TNM8 small intestine


			'''Lymph Node and Metastasis Information'''
			* Number of lymph nodes found
			* Number of tumor-positive lymph nodes found
			* Distant metastases?


			'''Response to Treatment'''
			* Pathological response after neoadjuvant therapy with Histological Tumor Regression Grading (HTRG)

Victor at 21:34, 8 May 2024

2024-05-08T21:34:45Z

Victor at 21:32, 8 May 2024

2024-05-08T21:32:41Z

@@ Line 3: / Line 3: @@
 This is a summary of the variables available in the database. You can download the complete data dictionary. [[https://support.mrdm.com/nl/downloads/documenten/ Click here to learn more].
-'''Comorbidities'''
+'''Patient Demographics and Identification:'''
 '''Patient Identification and Treatment Timeline'''
@@ Line 56: / Line 82: @@
 * Date of discharge and any readmissions within 30 days
 * Adjuvant therapy details and participation in oncological trials

← Older revision		Revision as of 21:34, 8 May 2024
Line 84:		Line 84:


	SARS-CoV-2 Suspected or Confirmed Infection		'''SARS-CoV-2 Suspected or Confirmed Infection'''
	* Presence of a clinical suspicion or test for SARS-CoV-2 infection prior to and up to 30 days post-admission.		* Presence of a clinical suspicion or test for SARS-CoV-2 infection prior to and up to 30 days post-admission.
	* Date of the first suspicion of SARS-CoV-2 infection.		* Date of the first suspicion of SARS-CoV-2 infection.
Line 92:		Line 92:


	Preoperative and Postoperative COVID-19 Testing		'''Preoperative and Postoperative COVID-19 Testing'''
	* Number of preoperative RT-PCR tests and the date of the first test.		* Number of preoperative RT-PCR tests and the date of the first test.
	* Date of the first preoperative CT thorax with COVID-19 concern and CORADS 4-5 score.		* Date of the first preoperative CT thorax with COVID-19 concern and CORADS 4-5 score.
Line 100:		Line 100:


	Patient Characteristics		'''Patient Characteristics'''
	* Symptoms indicative of COVID-19 (e.g., cough, fever, dyspnea, loss of smell/taste).		* Symptoms indicative of COVID-19 (e.g., cough, fever, dyspnea, loss of smell/taste).
	* Patient's smoking status and pack-years.		* Patient's smoking status and pack-years.
Line 106:		Line 106:


	Surgical and Intensive Care Considerations		'''Surgical and Intensive Care Considerations'''
	* Presence of preoperative COVID-19 related complications (e.g., ARDS, acute renal failure, arrhythmias, thromboembolic events).		* Presence of preoperative COVID-19 related complications (e.g., ARDS, acute renal failure, arrhythmias, thromboembolic events).
	* Impact on neoadjuvant treatment and changes in treatment plans or schedules.		* Impact on neoadjuvant treatment and changes in treatment plans or schedules.
Line 113:		Line 113:


	ICU Admission Related to COVID-19		'''ICU Admission Related to COVID-19'''
	* Presence and type of ICU admission related to COVID-19.		* Presence and type of ICU admission related to COVID-19.
	* Type of respiratory support during ICU stay (e.g., prone ventilation, ECMO).		* Type of respiratory support during ICU stay (e.g., prone ventilation, ECMO).
	* ICU admission and discharge dates and durations.		* ICU admission and discharge dates and durations.
	* Destination after ICU discharge.		* Destination after ICU discharge.